The impressive correlation between coronary artery disease and alterations in glucose metabolism has raised the likelihood that atherosclerosis and type 2 diabetes may share common antecedents. Diabetes mellitus has become a diagnosis of considerable and ominous importance in cardiovascular medicine. Despite considerable improvements in the treatment of cardiovascular diseases, there is alarming evidence that patients with diabetes have hardly experienced any advantages from recent therapeutic achievements compared with their non-diabetic counterparts. The primary purpose of Integrative Diabetes and Cardiovascular Diseases is to act as a source of information, usable by those caring for patients with diabetes mellitus who are thereby at risk for development of cardiovascular diseases which all too often appear with time.
Aim and Scope
The aim of the Integrative Diabetes and Cardiovascular Diseases (ISSN: 2637-4587) is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and cardiovascular diseases. The journal provides a home for all types of scientific communications related to the diabetes/cardiovascular interrelationship which include genetic, experimental, clinical, pharmacological, epidemiological, molecular biology and laboratory research. It is a journal for the health care practitioner that is intended to increase knowledge, stimulate research, and promote better management of people with diabetes and cardiovascular diseases.
The journal mainly focuses on following topics, but are not limited to: Stereochemistry, Epidemiology, Gastrointestinal Disorders, Hypertension and Hyperlipidemia, Impaired Glucose Tolerance, Insulin Resistance, Insulin Therapy, Islet Transplantation, Renal Failure and Impotence, Type 1 and 2 Diabetes, Acute Coronary Syndromes, Arrhythmias, Atrial Fibrillation, Cardiovascular Biology, Blood Transfusion, Cardiac Anesthesia, Cardiovascular Gene Therapy, Cardiac Development, Congenital Heart Disease, Coronary Stent, Coronary Artery diseases, Congenital Heart Disease, Diagnostic Imaging and Biomarkers, Vascular Diseases and Surgery and Interventional Cardiology.